LFA Development: Proof-of-Concept

​​​At the Proof-of-Concept (PoC) stage, the objective is to demonstrate that a proposed biological detection principle can function in a Lateral Flow Assay format. More than one assay architecture may be capable of meeting a given diagnostic aim, so this phase focuses on rapid experimental evaluation and comparison of options before progressing to full Feasibility.

​

Fleet Bioprocessing Ltd’s PoC development service is designed for customers who may already have selected antibody pairs or completed antibody screening studies, as well as those who have candidate reagents but require confirmation that their concept is viable in a Lateral Flow format.

The outcome is typically a single prototype assay design that can either progress into Feasibility or be used directly to support early, exploratory clinical or research studies.

​​

Our PoC service offers a focused and cost effective entry point into Lateral Flow development. Get in touch to discuss how we can support your assay concept.

​